Financials data is unavailable for this security.
View more
Year on year Yamashita Health Care Holdings Inc grew net income 165.30% from 219.00m to 581.00m primarily through revenue growth (58.20bn to 61.56bn). For while the costs associated with cost of goods, selling, general and administrative and debt all increased as a percentage of sales, the 5.77% growth in revenues contributed enough to still see net income improve.
| Gross margin | 13.74% |
|---|---|
| Net profit margin | 0.80% |
| Operating margin | 1.19% |
| Return on assets | 2.11% |
|---|---|
| Return on equity | 6.12% |
| Return on investment | 5.74% |
More ▼
Cash flow in JPYView more
In 2024, cash reserves at Yamashita Health Care Holdings Inc fell by 525.00m. However, the company earned 878.00m from its operations for a Cash Flow Margin of 1.43%. In addition the company used 1.07bn on investing activities and also paid 335.00m in financing cash flows.
| Cash flow per share | 284.89 |
|---|---|
| Price/Cash flow per share | 7.84 |
| Book value per share | 3,411.07 |
|---|---|
| Tangible book value per share | 3,261.44 |
More ▼
Balance sheet in JPYView more
| Current ratio | 1.21 |
|---|---|
| Quick ratio | 1.01 |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 45.83% and 165.58%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is in-line with the industry average relative to its peers, while earnings per share growth is above the industry average.
| Div yield(5 year avg) | 3.16% |
|---|---|
| Div growth rate (5 year) | 10.76% |
| Payout ratio (TTM) | 34.73% |
| EPS growth(5 years) | 32.13 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 133.81 |
More ▼
